Cargando…

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing

BACKGROUND: Germline BRCA1 and BRCA2 mutations (gBRCAm) can inform pancreatic cancer (PC) risk and treatment but most of the available information is derived from white patients. The ethnic and geographic variability of gBRCAm prevalence and of germline BRCA (gBRCA) testing uptake in PC globally is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paiella, S., Azzolina, D., Gregori, D., Malleo, G., Golan, T., Simeone, D.M., Davis, M.B., Vacca, P.G., Crovetto, A., Bassi, C., Salvia, R., Biankin, A.V., Casolino, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163165/ https://www.ncbi.nlm.nih.gov/pubmed/36822114 http://dx.doi.org/10.1016/j.esmoop.2023.100881

Ejemplares similares

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
por: Casolino, Raffaella, et al.
Publicado: (2021)

Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
por: Golan, Talia, et al.
Publicado: (2023)

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
por: Casolino, Raffaella, et al.
Publicado: (2022)

Seasonal variations in pancreatic surgery outcome A retrospective time-trend analysis of 2748 Whipple procedures
por: Marchegiani, Giovanni, et al.
Publicado: (2020)

Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Disparities in germline testing among racial minorities with prostate cancer
por: Weise, Nicole, et al.
Publicado: (2021)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy
por: Rossi, Gabriella, et al.
Publicado: (2022)

Germline BRCA2 mutations in men with breast cancer.
por: Mavraki, E., et al.
Publicado: (1997)

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
por: Petrovics, Gyorgy, et al.
Publicado: (2018)

Age-dependent penetrance of different germline mutations in the BRCA1 gene
por: Al-Mulla, F, et al.
Publicado: (2009)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
por: Torres, D., et al.
Publicado: (2017)

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
por: Mitchell, Gillian, et al.
Publicado: (2005)

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
por: Hammel, P, et al.
Publicado: (2019)

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
por: Mazzarotto, Renzo, et al.
Publicado: (2020)

Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020
por: Marchegiani, Giovanni, et al.
Publicado: (2021)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Morphological predictors of BRCA1 germline mutations in young women with breast cancer
por: Southey, M C, et al.
Publicado: (2011)

Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)

Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer
por: Sandini, Marta, et al.
Publicado: (2023)

Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: Case report
por: Paiella, Salvatore, et al.
Publicado: (2014)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
por: de Jonge, Marthe M, et al.
Publicado: (2021)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
por: Thiffault, I, et al.
Publicado: (2004)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)

Malignant Brenner tumor associated with a germline BRCA2 mutation
por: Toboni, Michael D., et al.
Publicado: (2017)

Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study
por: Paiella, Salvatore, et al.
Publicado: (2022)

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
por: Henouda, Sarra, et al.
Publicado: (2016)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
por: Vos, Shoko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r90ii0skg2kr6lohv5leac6c36